Integrated Risk Management in Biomaterials Design and Manufacture
The Electrospinning Company was invited into the BIORIMA European H2020 funded project as an industrial partner due to their experience in the design, development, and manufacture of nanoscale biomaterials. As a member of the BIORIMA consortium, The Electrospinning Company contributed to the development of the Integrated Risk Management (IRM) framework and is now applying it… Read more »
£4.5M Investment Led by Confluent Medical
Proceeds to be used to expand electrospinning capabilities & capacity, driving company growth Harwell, UK, May 4 2021 – The Electrospinning Company (Electrospinning), a leader in the development and manufacture of nanofibrous biomaterials for use in tissue regenerative devices, has completed a £4.5m ($6.3m) fundraising round, led by US materials science company Confluent Medical Technologies Inc. (Confluent) as a strategic investor…. Read more »
Corneal Case Study
Read how close partnership with our client helped overcome technological & pandemic challenges.
MedCity Company of the Month
Each month MedCity profiles an innovative, growing company from across the Greater South East of England. The Electrospinning Company is a pioneer in design and manufacture of implantable biomaterials and they have recently expanded into purpose-built cleanroom facilities at the Harwell Campus to increase their production capabilities. We spoke with Ann Kramer, CEO, about their work… Read more »